{"entity":{"type":"insider","cik":"0001670382","url":"/insider/0001670382","json_url":"/insider/0001670382.json","name":"Glenn Jeffrey S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":5,"first":"2016-11-21","last":"2022-12-27","span_basis":"filed_date"},"name_variants":[{"name":"Glenn Jeffrey S","source":"filing","n_filings":5,"first_seen":"2016-11-21","last_seen":"2022-12-27"}],"transactions":[{"id":6604783,"accession":"0001140361-22-047070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-22-047070","line_url":"/filing/0001140361-22-047070#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.2795,"price_display":"1.28","price_state":"stated","total_value":127950.0,"total_display":"127,950.00","total_whole":"127,950","shares_owned_after":182355.0,"shares_owned_after_display":"182,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":2141777,"accession":"0001209191-20-046449","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-046449","line_url":"/filing/0001209191-20-046449","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.42053,"price_display":"11.42","price_state":"stated","total_value":57102.65,"total_display":"57,102.65","total_whole":"57,103","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-12","scope":"insider","n_lines":2},{"id":2141775,"accession":"0001209191-20-046449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046449","line_url":"/filing/0001209191-20-046449#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.4927,"price_display":"11.49","price_state":"stated","total_value":57463.5,"total_display":"57,463.50","total_whole":"57,464","shares_owned_after":71355.0,"shares_owned_after_display":"71,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-11","filed_date":"2020-08-12","scope":"insider"},{"id":2468125,"accession":"0001209191-20-019682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-019682","line_url":"/filing/0001209191-20-019682#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":5.0271,"price_display":"5.03","price_state":"stated","total_value":150813.0,"total_display":"150,813.00","total_whole":"150,813","shares_owned_after":66355.0,"shares_owned_after_display":"66,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-17","scope":"insider"},{"id":4945162,"accession":"0001209191-17-051449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-051449","line_url":"/filing/0001209191-17-051449#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":9.53,"price_display":"9.53","price_state":"stated","total_value":142950.0,"total_display":"142,950.00","total_whole":"142,950","shares_owned_after":31355.0,"shares_owned_after_display":"31,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-05","scope":"insider"},{"id":3185257,"accession":"0001209191-16-151477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-151477","line_url":"/filing/0001209191-16-151477#line-2","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":460.0,"shares_display":"460","price_per_share":12.9,"price_display":"12.90","price_state":"stated","total_value":5934.0,"total_display":"5,934.00","total_whole":"5,934","shares_owned_after":460.0,"shares_owned_after_display":"460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-21","scope":"insider"},{"id":3185254,"accession":"0001209191-16-151477","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-151477","line_url":"/filing/0001209191-16-151477#line-1","is_derivative":false,"issuer_cik":"0001305253","issuer_name":"Eiger BioPharmaceuticals, Inc.","issuer_ticker":"EIGR","issuer_name_source":null,"issuer_url":"/issuer/0001305253","owner_cik":"0001670382","owner_name":"Glenn Jeffrey S","owner_display_name":"Glenn Jeffrey S","owner_url":"/insider/0001670382","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":12.73,"price_display":"12.73","price_state":"stated","total_value":190950.0,"total_display":"190,950.00","total_whole":"190,950","shares_owned_after":16355.0,"shares_owned_after_display":"16,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-17","filed_date":"2016-11-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001305253","name":"Eiger BioPharmaceuticals, Inc.","url":"/issuer/0001305253","role":"Director","n_filings":5,"first_seen":"2016-11-21","last_seen":"2022-12-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001670382","retrieved_at":"2026-08-25T16:46:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}